Bicycle Therapeutics (BCYC) Depreciation and Depletion (2018 - 2024)
Bicycle Therapeutics posted quarterly Depreciation and Depletion of $1.6 million for Q2 2024, little changed year-on-year from $1.6 million in Q3 2023, and down 5.88% on a QoQ basis from $1.7 million in Q1 2024.
Bicycle Therapeutics (BCYC) has 7 years of Depreciation and Depletion data on file, last reported at $1.6 million in Q2 2024.
- For the quarter ending Q2 2024, Depreciation and Depletion changed 0.0% year-over-year to $1.6 million; the trailing twelve-month figure through Jun 2024 stood at $6.6 million (up 10.0% YoY), and the FY2023 full-year result was $6.5 million, up 75.68% from the prior year.
- Depreciation and Depletion for Q2 2024 stood at $1.6 million, down from $1.7 million in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $1.7 million in Q3 2023 and bottomed at $300000.0 in Q1 2020.
- The 5-year median for Depreciation and Depletion is $500000.0 (2020), against an average of $900000.0.
- The widest annual swing landed in 2020, when Depreciation and Depletion tumbled 50.0%; it then jumped 333.33% in 2022.
- A 5-year view of Depreciation and Depletion shows it stood at $400000.0 in 2020, then changed by 0.0% to $400000.0 in 2021, then soared by 275.0% to $1.5 million in 2022, then climbed by 6.67% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024.
- The last three Depreciation and Depletion figures came in at $1.6 million (Q2 2024), $1.7 million (Q1 2024), and $1.6 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Bicycle Therapeutics | 326.82 Mn | 326.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | 1.60 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Sep 30, 2023 | 1.70 Mn |
| Sep 30, 2023 | 1.70 Mn |
| Jun 30, 2023 | 1.60 Mn |
| Jun 30, 2023 | 1.60 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | 1.30 Mn |
| Sep 30, 2022 | 1.30 Mn |
| Jun 30, 2022 | 600,000.00 |
| Jun 30, 2022 | 600,000.00 |
| Mar 31, 2022 | 400,000.00 |
| Mar 31, 2022 | 400,000.00 |
| Dec 31, 2021 | 400,000.00 |
| Dec 31, 2021 | 400,000.00 |
| Sep 30, 2021 | 300,000.00 |
| Sep 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 300,000.00 |
| Mar 31, 2021 | 300,000.00 |
| Mar 31, 2021 | 300,000.00 |
| Dec 31, 2020 | 400,000.00 |
| Dec 31, 2020 | 400,000.00 |
| Sep 30, 2020 | 300,000.00 |
| Sep 30, 2020 | 300,000.00 |
| Jun 30, 2020 | 300,000.00 |
| Jun 30, 2020 | 300,000.00 |
| Mar 31, 2020 | 300,000.00 |
| Mar 31, 2020 | 300,000.00 |
| Dec 31, 2019 | 300,000.00 |
| Dec 31, 2019 | 300,000.00 |
| Sep 30, 2019 | 200,000.00 |
| Sep 30, 2019 | 200,000.00 |
| Jun 30, 2019 | 600,000.00 |
| Jun 30, 2019 | 600,000.00 |
| Mar 31, 2019 | 200,000.00 |
| Mar 31, 2019 | 200,000.00 |
| Dec 31, 2018 | 200,000.00 |
| Dec 31, 2018 | 200,000.00 |
| Sep 30, 2018 | 200,000.00 |
| Sep 30, 2018 | 200,000.00 |
| Jun 30, 2018 | 200,000.00 |
| Jun 30, 2018 | 200,000.00 |